Annual FCF
-$79.02 M
+$1.32 M+1.64%
December 31, 2023
Summary
- As of February 8, 2025, ALGS annual free cash flow is -$79.02 million, with the most recent change of +$1.32 million (+1.64%) on December 31, 2023.
- During the last 3 years, ALGS annual FCF has fallen by -$2.69 million (-3.52%).
- ALGS annual FCF is now -59.46% below its all-time high of -$49.55 million, reached on December 31, 2019.
Performance
ALGS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$20.13 M
-$627.00 K-3.22%
September 30, 2024
Summary
- As of February 8, 2025, ALGS quarterly free cash flow is -$20.13 million, with the most recent change of -$627.00 thousand (-3.22%) on September 30, 2024.
- Over the past year, ALGS quarterly FCF has increased by +$2.54 million (+11.20%).
- ALGS quarterly FCF is now -47.89% below its all-time high of -$13.61 million, reached on June 30, 2023.
Performance
ALGS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$85.11 M
+$221.00 K+0.26%
September 30, 2024
Summary
- As of February 8, 2025, ALGS TTM free cash flow is -$85.11 million, with the most recent change of +$221.00 thousand (+0.26%) on September 30, 2024.
- Over the past year, ALGS TTM FCF has dropped by -$6.09 million (-7.71%).
- ALGS TTM FCF is now -297.53% below its all-time high of -$21.41 million, reached on March 31, 2020.
Performance
ALGS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ALGS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.6% | +11.2% | -7.7% |
| 3 y3 years | -3.5% | +10.1% | -4.1% |
| 5 y5 years | - | +10.1% | -4.1% |
ALGS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.2% | -47.9% | +46.8% | -21.6% | +27.0% |
| 5 y | 5-year | -59.5% | +32.2% | -47.9% | +46.8% | -297.5% | +27.0% |
| alltime | all time | -59.5% | +32.2% | -47.9% | +46.8% | -297.5% | +27.0% |
Aligos Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.13 M(+3.2%) | -$85.11 M(-0.3%) |
| Jun 2024 | - | -$19.50 M(-14.5%) | -$85.33 M(+7.4%) |
| Mar 2024 | - | -$22.82 M(+0.7%) | -$79.44 M(+0.5%) |
| Dec 2023 | -$79.02 M(-1.6%) | -$22.66 M(+11.4%) | -$79.02 M(+7.9%) |
| Sep 2023 | - | -$20.35 M(+49.5%) | -$73.22 M(+4.6%) |
| Jun 2023 | - | -$13.61 M(-39.2%) | -$70.02 M(-14.4%) |
| Mar 2023 | - | -$22.39 M(+32.7%) | -$81.78 M(+1.8%) |
| Dec 2022 | -$80.33 M | -$16.87 M(-1.6%) | -$80.33 M(-20.7%) |
| Sep 2022 | - | -$17.14 M(-32.4%) | -$101.27 M(-7.6%) |
| Jun 2022 | - | -$25.37 M(+21.1%) | -$109.60 M(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$20.95 M(-44.6%) | -$107.40 M(-7.9%) |
| Dec 2021 | -$116.55 M(+52.7%) | -$37.82 M(+48.5%) | -$116.55 M(+18.3%) |
| Sep 2021 | - | -$25.46 M(+9.9%) | -$98.48 M(+9.5%) |
| Jun 2021 | - | -$23.17 M(-23.0%) | -$89.93 M(+5.8%) |
| Mar 2021 | - | -$30.10 M(+52.5%) | -$85.02 M(+11.4%) |
| Dec 2020 | -$76.33 M(+54.0%) | -$19.75 M(+16.8%) | -$76.33 M(+34.9%) |
| Sep 2020 | - | -$16.91 M(-7.4%) | -$56.58 M(+42.6%) |
| Jun 2020 | - | -$18.26 M(-14.7%) | -$39.67 M(+85.3%) |
| Mar 2020 | - | -$21.41 M | -$21.41 M |
| Dec 2019 | -$49.55 M | - | - |
FAQ
- What is Aligos Therapeutics annual free cash flow?
- What is the all time high annual FCF for Aligos Therapeutics?
- What is Aligos Therapeutics annual FCF year-on-year change?
- What is Aligos Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly FCF year-on-year change?
- What is Aligos Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Aligos Therapeutics?
- What is Aligos Therapeutics TTM FCF year-on-year change?
What is Aligos Therapeutics annual free cash flow?
The current annual FCF of ALGS is -$79.02 M
What is the all time high annual FCF for Aligos Therapeutics?
Aligos Therapeutics all-time high annual free cash flow is -$49.55 M
What is Aligos Therapeutics annual FCF year-on-year change?
Over the past year, ALGS annual free cash flow has changed by +$1.32 M (+1.64%)
What is Aligos Therapeutics quarterly free cash flow?
The current quarterly FCF of ALGS is -$20.13 M
What is the all time high quarterly FCF for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly free cash flow is -$13.61 M
What is Aligos Therapeutics quarterly FCF year-on-year change?
Over the past year, ALGS quarterly free cash flow has changed by +$2.54 M (+11.20%)
What is Aligos Therapeutics TTM free cash flow?
The current TTM FCF of ALGS is -$85.11 M
What is the all time high TTM FCF for Aligos Therapeutics?
Aligos Therapeutics all-time high TTM free cash flow is -$21.41 M
What is Aligos Therapeutics TTM FCF year-on-year change?
Over the past year, ALGS TTM free cash flow has changed by -$6.09 M (-7.71%)